Insights

We’re acknowledged for our strong market insight and technical know-how

Life sciences
Insights

What MHRA medical devices regulation consultation seeks to address

8 December 2021
Read more
Insights

Corporate team advises on major cross-border life sciences transaction

27 October 2021
Read more
Insights

Regulation of GMOs: time to modify the law?

26 August 2021
Read more
News

Penningtons Manches Cooper advises Oxford Cannabinoid Technologies Holdings plc on its main market IPO

21 May 2021
Read more
News

Penningtons Manches Cooper advises biomaterials company on £4.5 million fundraising round

17 May 2021
Read more
Insights

National Security and Investment Act: implications for life sciences businesses

13 May 2021
Read more
News

Penningtons Manches Cooper advise medtech spin-out on Series A funding round

11 May 2021
Read more
Insights

First Innovation Passport awarded under UK MHRA’s Innovative Licensing and Access Pathway

4 May 2021
Read more
Insights

Penningtons Manches Cooper acts for Metrion Biosciences Ltd on £2.7 million new equity financing

29 April 2021
Read more
News

Penningtons Manches Cooper advises Oxford University spin-out aiming to develop cancer vaccines

23 April 2021
Read more
News

Penningtons Manches Cooper advises on medtech funding round

22 April 2021
Read more
Insights

Illumina Cambridge Limited v Latvia MGI Tech SIA & Others – the “chocolate teapot” theory

21 April 2021
Read more
Back to Life sciences